AGIO ▲ +2.3% - Agios Pharmaceuticals, Inc.
$AGIO - Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026
04-NOV-2026 09:01 AM ET
Share this post
More filings for $AGIO
AGIO ▲ +0.1% - Agios Pharmaceuticals, Inc.Oct 30, 2026AGIO ▲ +0.8% - Agios Pharmaceuticals, Inc.Oct 20, 2026$AGIO SEC Filing Update (03-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 3, 2026$AGIO SEC Filing Update (02-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 2, 2026
View full $AGIO filing history →💬 Comments
Loading comments…
Leave a comment